SynthesisFrontiers in psychiatry2026
Psychiatric readmission of children and adolescents in China: a scoping review.
Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Psychiatric readmission in children and adolescents is not uncommon in developed countries. Despite increasing medical resources being allocated to children and adolescents with mental health problems in China, the effectiveness of psychiatric inpatient treatment and the current situation of rehospitalization are not well documented. Methods: A scoping review was conducted to describe the actual prevalence, associative factors and potential interventions for psychiatric readmission among children and adolescents in China. Documents indexed in PubMed, PsycINFO, Web of Science, Wanfang and CNKI were searched for up to May 2025. Two authors independently reviewed the records. Results: Of the 723 records, 19 met the inclusion criteria. For children and adolescents with heterogeneous mental health diagnoses, the weighted average readmission rate was 18.6% overall, with rates of 8.6% for follow-up periods under one year and 20.9% for periods of one year or more, respectively. The readmission rate was higher in patients with schizophrenia spectrum disorders and lower in those with mood disorders. The risk factors related to psychiatric readmission included longer follow-up duration and hospitalization of the initial treatment, poor adherence to medication, frequent changes in treatment regimens, poor treatment responses, childhood onset, family history of mental illness, excitability/hostility, insufficient sleep, anxiety, and obesity. The protective factors related to psychiatric readmission included support from family, teachers and friends for patients with depression, and obsessive-compulsive symptoms for patients with schizophrenia. Only preliminary evidence was found regarding interventions to reduce readmission for pediatric psychiatric inpatients or their parents. Conclusions: This review provides a significant overview of current psychiatric inpatient treatments for children and adolescents in China. Our findings underscore the notable frequency of psychiatric readmissions, highlighting the need for targeted interventions, particularly for children and adolescents exhibiting certain clinical features and challenges with treatment adherence or responsiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.